These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 15454481
1. Final adult height of patients who received hematopoietic cell transplantation in childhood. Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR. Blood; 2005 Feb 01; 105(3):1348-54. PubMed ID: 15454481 [Abstract] [Full Text] [Related]
2. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Holm K, Nysom K, Rasmussen MH, Hertz H, Jacobsen N, Skakkebaek NE, Krabbe S, Müller J. Bone Marrow Transplant; 1996 Jul 01; 18(1):163-70. PubMed ID: 8832010 [Abstract] [Full Text] [Related]
3. Final height after transplantation in childhood. Bakker B, Oostdijk W, Wit JM. Blood; 2005 Oct 01; 106(7):2592-3; author reply 2593. PubMed ID: 16172255 [No Abstract] [Full Text] [Related]
4. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA). Isfan F, Kanold J, Merlin E, Contet A, Sirvent N, Rochette E, Poiree M, Terral D, Carla-Malpuech H, Reynaud R, Pereira B, Chastagner P, Simeoni MC, Auquier P, Michel G, Deméocq F. Bone Marrow Transplant; 2012 May 01; 47(5):684-93. PubMed ID: 21725370 [Abstract] [Full Text] [Related]
5. Final height and gonad function after total body irradiation during childhood. Couto-Silva AC, Trivin C, Esperou H, Michon J, Baruchel A, Lemaire P, Brauner R. Bone Marrow Transplant; 2006 Sep 01; 38(6):427-32. PubMed ID: 16878146 [Abstract] [Full Text] [Related]
6. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Clin Endocrinol (Oxf); 2007 Oct 01; 67(4):589-97. PubMed ID: 17590170 [Abstract] [Full Text] [Related]
7. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson MM, Pui CH. J Clin Oncol; 2002 Jul 01; 20(13):2959-64. PubMed ID: 12089225 [Abstract] [Full Text] [Related]
8. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone. Lanes R. Curr Pharm Biotechnol; 2000 Jul 01; 1(1):33-46. PubMed ID: 11467359 [Abstract] [Full Text] [Related]
9. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Frisk P, Arvidson J, Gustafsson J, Lönnerholm G. Bone Marrow Transplant; 2004 Jan 01; 33(2):205-10. PubMed ID: 14628079 [Abstract] [Full Text] [Related]
10. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone. de Muinck Keizer-Schrama S, Van den Broeck J, Sas T, Hokken-Koelega A. Horm Res; 1999 Jan 01; 51 Suppl 3():127-31. PubMed ID: 10592457 [Abstract] [Full Text] [Related]
11. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P. Bone Marrow Transplant; 1999 Nov 01; 24(10):1131-6. PubMed ID: 10578163 [Abstract] [Full Text] [Related]
12. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O'Reilly RJ, Sklar CA. Bone Marrow Transplant; 2007 Jul 01; 40(1):29-35. PubMed ID: 17468769 [Abstract] [Full Text] [Related]
13. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency. Reiter EO, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B. Horm Res; 2003 Jul 01; 60(Suppl 1):68-73. PubMed ID: 12955021 [Abstract] [Full Text] [Related]
14. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM. J Clin Endocrinol Metab; 2003 Aug 01; 88(8):3682-9. PubMed ID: 12915655 [Abstract] [Full Text] [Related]
15. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation. Adan L, Sainte-Rose C, Souberbielle JC, Zucker JM, Kalifa C, Brauner R. Med Pediatr Oncol; 2000 Jan 01; 34(1):14-9. PubMed ID: 10611579 [Abstract] [Full Text] [Related]
16. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM. J Clin Endocrinol Metab; 2004 Feb 01; 89(2):662-6. PubMed ID: 14764778 [Abstract] [Full Text] [Related]
17. Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood. Attanasio AF, Howell S, Bates PC, Blum WF, Frewer P, Quigley C, Shalet SM. Clin Endocrinol (Oxf); 2002 Apr 01; 56(4):503-7. PubMed ID: 11966743 [Abstract] [Full Text] [Related]
18. Final height and weight of long-term survivors of childhood malignancies. Müller HL, Klinkhammer-Schalke M, Kühl J. Exp Clin Endocrinol Diabetes; 1998 Apr 01; 106(2):135-9. PubMed ID: 9628245 [Abstract] [Full Text] [Related]
19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J. J Clin Endocrinol Metab; 2000 Oct 01; 85(10):3653-60. PubMed ID: 11061518 [Abstract] [Full Text] [Related]
20. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Zenaty D, Garel C, Limoni C, Czernichow P, Léger J. Clin Endocrinol (Oxf); 2003 May 01; 58(5):647-52. PubMed ID: 12699449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]